Alimpos, Eina Brylle .
HRN: 24-42-34 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/13/2024
01/20/2024
IV
125mg
Q6h
For Orif
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes